Showing 1,521 - 1,540 results of 2,274 for search '"type 2 diabetes"', query time: 0.11s Refine Results
  1. 1521

    Stress in Obesity and Associated Metabolic and Cardiovascular Disorders by Paul Holvoet

    Published 2012-01-01
    “…Obesity has significant implications for healthcare, since it is a major risk factor for both type 2 diabetes and the metabolic syndrome. This syndrome is a common and complex disorder combining obesity, dyslipidemia, hypertension, and insulin resistance. …”
    Get full text
    Article
  2. 1522

    Successful Use of Octreotide Therapy for Refractory Levofloxacin-Induced Hypoglycemia: A Case Report and Literature Review by Matthew R. Watson, Ceressa T. Ward, Amit Prabhakar, Babar Fiza, Vanessa Moll

    Published 2019-01-01
    “…We report a case of refractory fluoroquinolone-induced hypoglycemia in a patient with type-2 diabetes mellitus on glipizide that was successfully treated with octreotide. …”
    Get full text
    Article
  3. 1523

    Leupaxin promotes hepatic gluconeogenesis and glucose metabolism by coactivation with hepatic nuclear factor 4α by Xiaomin Luo, Fang Liu, Lijun Zhu, Caizhi Liu, Ruhui Shen, Xiaoyin Ding, Yufan Wang, Xiaofang Tang, Yongde Peng, Zhijian Zhang

    Published 2025-01-01
    “…Abnormal gluconeogenesis in the liver can lead to hyperglycemia, a key diagnostic marker and the primary pathological contributor to type 2 diabetes (T2D) and metabolic disorders. Hepatic nuclear factor-4 (HNF4α) is an important regulator of gluconeogenesis. …”
    Get full text
    Article
  4. 1524

    PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate by Robert I. Glazer, Hongyan Yuan, Zhihui Xie, Yuzhi Yin

    Published 2008-01-01
    “…PPARγ agonists are used by millions of people each year to treat type 2 diabetes but may also find additional utility as relatively nontoxic potentiators of chemotherapy. …”
    Get full text
    Article
  5. 1525

    Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus by Lung-Wen Tsai, Yi-Hsiang Lu, Rajni Dubey, Jeng-Fong Chiou

    Published 2021-01-01
    “…Clinically, it has also been revealed that the existence of nonalcoholic fatty liver disease (NAFLD) enhances the incidence of type 2 diabetes mellitus (T2DM), while T2DM exacerbates NAFLD to extremely severe forms of steatohepatitis, cirrhosis, and hepatocellular carcinoma. …”
    Get full text
    Article
  6. 1526

    Adropin as an indicator of T2DM and its complications by Hu Zhang, Ning Chen

    Published 2022-11-01
    “…Type 2 diabetes mellitus (T2DM) is one of metabolic diseases with the major inducer of obesity. …”
    Get full text
    Article
  7. 1527

    A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications by Francesca Conserva, Loreto Gesualdo, Massimo Papale

    Published 2016-01-01
    “…Diabetic nephropathy (DN), a microvascular complication occurring in approximately 20–40% of patients with type 2 diabetes mellitus (T2DM), is characterized by the progressive impairment of glomerular filtration and the development of Kimmelstiel-Wilson lesions leading to end-stage renal failure (ESRD). …”
    Get full text
    Article
  8. 1528

    Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children by Anna Alisi, Nadia Panera, Carlo Agostoni, Valerio Nobili

    Published 2011-01-01
    “…This study suggested that, in children, adolescents, and adults born SGA, insulin resistance could lead to other metabolic disorders: type 2 diabetes (DM2), dyslipidemia, and nonalcoholic fatty liver disease (NAFLD). …”
    Get full text
    Article
  9. 1529

    Emphysematous pyelonephritis with rare and severe iliac vascular complications: a case report and review by Pan Gao, Han Yang, Han Yang, Zhi Zhang

    Published 2025-01-01
    “…This report describes a 54-year-old man with type 2 diabetes who presented with right lumbar pain and was diagnosed with EPN complicated by right ureteral calculi and perinephric gas accumulation. …”
    Get full text
    Article
  10. 1530

    Bariatric Surgery, Polycystic Ovary Syndrome, and Infertility by James Butterworth, Jean Deguara, Cynthia-Michelle Borg

    Published 2016-01-01
    “…Bariatric surgery has been shown to conclusively improve life expectancy, quality of life, and comorbidities like type 2 diabetes and obstructive sleep apnea. However, further research is required to identify whether weight loss surgery results in significant improvement in fertility of women with PCOS and to investigate which operation has the best results.…”
    Get full text
    Article
  11. 1531

    Clinical condition of patients with Obesity Hypoventilation Syndrome (OHS): case report by Made Oka Heryana, Heru Widjono

    Published 2023-12-01
    “…We diagnosed her with obesity hypoventilation syndrome, type 2 diabetes, and stage 1 hypertension. During her five-day hospitalization, her condition improved. …”
    Get full text
    Article
  12. 1532

    Rehabilitative Treatment as an Alternative in Amputee Patients. Case Report and Literature Review by Ismaray Sacerio González, Elohilda de la Caridad Cruz Jiménez, Silvia Georgina de la Torre Castellanos

    Published 2023-11-01
    “…The case of a 52-year-old male patient is presented, with a history of type 2 diabetes mellitus and arterial hypertension controlled by treatment, in addition to suffering from hereditary thrombopathy treated with anticoagulants, which is why he underwent surgical treatment. …”
    Get full text
    Article
  13. 1533

    Virtual Screening as a Technique for PPAR Modulator Discovery by Stephanie N. Lewis, Josep Bassaganya-Riera, David R. Bevan

    Published 2010-01-01
    “…It is well recognized that PPARγ agonists have therapeutic applications as insulin sensitizers in type 2 diabetes or as anti-inflammatories. VS is a cost- and time-effective means for identifying small molecules that have therapeutic potential. …”
    Get full text
    Article
  14. 1534

    Impact of digital health interventions on glycemic control and weight management by Arvind Veluvali, Ashkan Dehghani Zahedani, Amir Hosseinian, Nima Aghaeepour, Tracey McLaughlin, Mark Woodward, Alex DiTullio, Noosheen Hashemi, Michael P. Snyder

    Published 2025-01-01
    “…Abstract This retrospective cohort study evaluates the impact of an AI-supported continuous glucose monitoring (CGM) mobile app (“January V2”) on glycemic control and weight management in 944 users, including healthy individuals and those with prediabetes or type 2 diabetes (T2D). The app, leveraging AI to personalize feedback, tracked users’ food intake, activity, and glucose responses over 14 days. …”
    Get full text
    Article
  15. 1535

    JAK inhibitors: a new choice for diabetes mellitus? by Mengjun Zhou, Qi Shen, Bo Li

    Published 2025-01-01
    “…Recently, several clinical cases involving the reversal of type 1 diabetes mellitus (T1DM) during treatment with JAK inhibitors have been reported, and clinical studies have described the improvement of type 2 diabetes mellitus (T2DM) during treatment with JAK inhibitors. …”
    Get full text
    Article
  16. 1536

    Diagnosis of a Morgagni-Stewart-Morel Syndrome in a Patient with Ischemic Stroke. Report of a Case by Masleidy Valladares Valle, Juan Ibrahim García Leonard, Ada Sánchez Lozano

    Published 2022-01-01
    “…The case of a 77-year-old patient with a history of type 2 diabetes mellitus, systemic arterial hypertension and psychiatric disorder, who was admitted to the Neurology Service of the Dr. …”
    Get full text
    Article
  17. 1537

    Spatiotemporal Regulators for Insulin-Stimulated GLUT4 Vesicle Exocytosis by Xiaoxu Zhou, Ping Shentu, Yingke Xu

    Published 2017-01-01
    “…Importantly, the dysfunction of insulin-regulated GLUT4 trafficking is strongly linked with peripheral insulin resistance and type 2 diabetes in human. The insulin signaling pathway, key signaling molecules involved, and precise trafficking itinerary of GSVs are largely identified. …”
    Get full text
    Article
  18. 1538

    Ozone therapy as support in the treatment of diabetic foot ulcer. A case report by Isidro Matos Lamote, Jorge Enrique Rodríguez León, Carlos García Arencibia, Maydelin Pérez Reina

    Published 2023-07-01
    “…The case of a 43-years-old patient with a diagnosis of type 2 diabetes mellitus, of seven years of evolution, referred from the Emergency Department of the Dr. …”
    Get full text
    Article
  19. 1539

    Metformin: A Possible Option in Cancer Chemotherapy by Chidiebere V. Ugwueze, Odunze J. Ogamba, Ekenechukwu E. Young, Belonwu M. Onyenekwe, Basil C. Ezeokpo

    Published 2020-01-01
    “…Metformin has been used for a long time as an antidiabetic medication for type 2 diabetes. It is used either as a monotherapy or in combination with other antidiabetic medications. …”
    Get full text
    Article
  20. 1540

    Physical Activity and Arterial Stiffness: A Narrative Review by Jinyu Yang, Xiaoqian Chen, Xiang Chen, Lihua Li

    Published 2025-01-01
    “…These benefits are especially significant in populations with higher cardiovascular risk, such as those with type 2 diabetes mellitus and hypertension. Therefore, maintaining an active lifestyle into older age is crucial for vascular health and may contribute to healthy aging.…”
    Get full text
    Article